| Martin Werner Hartkopf, MD | |
|
115 Lincoln St, Framingham, MA 01702-6358 | |
| (508) 383-1000 | |
| Not Available |
| Full Name | Martin Werner Hartkopf |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 14 Years |
| Location | 115 Lincoln St, Framingham, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851821284 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 272680 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sturdy Memorial Hospital | Attleboro, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sturdy Memorial Associates Inc | 9537152806 | 177 |
News Archive
Scientists of Friedrich Schiller University Jena and Jena University Hospital decode the antihypertensive impact of omega-3 fatty acids. In two newly published articles for the well-known science magazine 'Proceedings of the National Academy of Sciences, USA' they describe how they analyzed the impact of omega-3 fatty acids on a systemic level and they also described the underlying molecular mechanisms for the first time.
The devastating consequences of the opioid crisis are far-reaching in the United States, impacting public health as well as social and economic welfare.
Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.
Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to radiation therapy and improves survival in animal models of the disease.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
› Verified 5 days ago
| Entity Name | Sturdy Memorial Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063866176 PECOS PAC ID: 9537152806 Enrollment ID: O20160811001583 |
News Archive
Scientists of Friedrich Schiller University Jena and Jena University Hospital decode the antihypertensive impact of omega-3 fatty acids. In two newly published articles for the well-known science magazine 'Proceedings of the National Academy of Sciences, USA' they describe how they analyzed the impact of omega-3 fatty acids on a systemic level and they also described the underlying molecular mechanisms for the first time.
The devastating consequences of the opioid crisis are far-reaching in the United States, impacting public health as well as social and economic welfare.
Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.
Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to radiation therapy and improves survival in animal models of the disease.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Martin Werner Hartkopf, MD 115 Lincoln St, Framingham, MA 01702-6358 Ph: (508) 383-1000 | Martin Werner Hartkopf, MD 115 Lincoln St, Framingham, MA 01702-6358 Ph: (508) 383-1000 |
News Archive
Scientists of Friedrich Schiller University Jena and Jena University Hospital decode the antihypertensive impact of omega-3 fatty acids. In two newly published articles for the well-known science magazine 'Proceedings of the National Academy of Sciences, USA' they describe how they analyzed the impact of omega-3 fatty acids on a systemic level and they also described the underlying molecular mechanisms for the first time.
The devastating consequences of the opioid crisis are far-reaching in the United States, impacting public health as well as social and economic welfare.
Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.
Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to radiation therapy and improves survival in animal models of the disease.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
› Verified 5 days ago
Dr. Wendy Elizabeth Gray, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 260 Cochituate Rd, Framingham, MA 01701 Phone: 508-628-9660 Fax: 508-628-9668 | |
Dr. Sira Korpaisarn, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1130 | |
Dagem Getahun, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1555 | |
Dr. Pedro Arthur Macedo De Freitas, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1000 | |
Yung-chen Wu, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1572 | |
Richard Stephen Blumenfeld, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 761 Worcester Rd, Framingham, MA 01701 Phone: 508-879-7904 Fax: 508-872-8594 | |
Rejane Guerrier, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 959 Concord St Ste 200, Framingham, MA 01701 Phone: 508-532-0223 Fax: 508-875-0049 |